Corbion, a international leader in sustainable components, and Brain Biotech AG, a innovators in specialty enzyme and microbial technology, have declared a planned collaboration to generate pioneering biobased antimicrobial compounds and derivatives. This partnership target to increase the development of natural preservation solutions for food producers at the same time as meeting increasing purchaser requirement for clean-label, nature-based products.
“At Corbion, improving nature-primarily based ingredient technologies and showing their performance is central to our mission of preserving what matters,” stated Domenico Vulcano, Vice President of Global Innovation at Corbion. “Partnering with Brain Biotech lets in us to combine our abilities in food systems with their innovative microbial and enzyme technologies, getting the next generation of sustainable food preservation solutions to market faster.”
Brain Biotech provides its strengths in specialty enzyme technology, microbial strain development, and bioprocess innovation, along with experience with the technology licensing accomplice. Corbion complements this with deep observation into food systems, biobased preservation, and big-scale testing and commercialization capabilities.
“We are excited to collaborate with Corbion to unlock new opportunities in sustainable, bio-based solutions,” stated Dr. Martin Langer, Managing Director & Executive Vice President at BRAIN Biotech AG. “Our shared vision, complementary expertise, and robust partnership will deliver meaningful innovation that advantage food producers and clients globally.”
